<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01410084</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00014152</org_study_id>
    <nct_id>NCT01410084</nct_id>
  </id_info>
  <brief_title>Improving Vitamin D Status in Home-bound Elders</brief_title>
  <acronym>MOW VitD</acronym>
  <official_title>Improving Vitamin D Status in Home-bound Elders: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the past two decades, the role of vitamin D has extended beyond bone health to encompass a
      wide range of biological activities important to physical function in older adults. A growing
      body of evidence now shows that circulating 25-hydroxyvitamin D (25(OH)D) levels &lt; 75 nmol/L
      (&lt; 30 ng/mL)) are associated with physical impairments such as reduced walking speed and
      impaired balance as well as falls. Older adults are at risk for low levels of
      25-hydroxyvitamin D because of reduced exposure to ultraviolet B radiation, reduced
      efficiency of previtamin D synthesis in the skin, and low dietary intake. Although data from
      the National Health and Nutrition Examination Survey (NHANES) 2000-2004 indicate that frank
      vitamin D deficiency (serum 25(OH)D &lt; 25 nmol/L [10 ng/mL]) is rare in the U.S. (5% or less),
      vitamin D insufficiency (serum 25(OH)D &lt; 75 nmol/L [30 ng/mL]) is prevalent (~75%) among
      older adults. Older home-bound adults are a vulnerable subgroup of older adults for poor
      dietary intake and nutritional health, nutrition-related health conditions, and functional
      decline and disability. The primary goal of this pilot study is to assess the feasibility of
      a partnership with Senior Services of Forsyth County to address vitamin D insufficiency in
      home-bound older adults receiving home-delivered meals. A secondary goal is to obtain
      preliminary data on the effectiveness of vitamin D supplementation on improving vitamin D
      levels and reducing falls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the past two decades, the role of vitamin D has extended beyond bone health to encompass a
      wide range of biological activities important to physical function in older adults. A growing
      body of evidence now shows that circulating 25-hydroxyvitamin D (25(OH)D) levels &lt; 75 nmol/L
      (&lt; 30 ng/mL)) are associated with physical impairments such as reduced walking speed and
      impaired balance as well as falls. Older adults are at risk for low levels of
      25-hydroxyvitamin D because of reduced exposure to ultraviolet B radiation, reduced
      efficiency of previtamin D synthesis in the skin, and low dietary intake. Although data from
      the National Health and Nutrition Examination Survey (NHANES) 2000-2004 indicate that frank
      vitamin D deficiency (serum 25(OH)D &lt; 25 nmol/L [10 ng/mL]) is rare in the U.S. (5% or less),
      vitamin D insufficiency (serum 25(OH)D &lt; 75 nmol/L [30 ng/mL]) is prevalent (~75%) among
      older adults. Older home-bound adults are a vulnerable subgroup of older adults for poor
      dietary intake and nutritional health, nutrition-related health conditions, and functional
      decline and disability. The primary goal of this pilot study is to assess the feasibility of
      a partnership with Senior Services of Forsyth County to address vitamin D insufficiency in
      home-bound older adults receiving home-delivered meals. The investigators will accomplish
      this goal by conducting a 5-month randomized, controlled trial in 200 older Meals-on-Wheels
      (MOW) recipients randomized to receive monthly either (1) 100,000 IU vitamin D3 or (2) an
      active placebo (vitamin E) to achieve the following specific aims:

      Aim 1: Determine the prevalence of falls and risk of vitamin D insufficiency in 200 MOW
      recipients.

      Aim 2: Assess the feasibility of the vitamin D intervention delivered through the MOW
      program.

      Aim 3: Obtain preliminary data on the effectiveness of the intervention on improving vitamin
      D status and reducing falls.

      Data from this pilot study will: 1) provide estimates of the prevalence of falls and vitamin
      D insufficiency in home-bound older adults participating in the Forsyth County MOW program;
      2) provide estimates of participant compliance and drop-out to a vitamin supplementation
      trial delivered as part of the MOW program; 3) provide evidence for the efficacy of the
      vitamin D dose proposed in remediating vitamin D insufficiency; and 4) provide preliminary
      data on the potential benefit of vitamin D supplementation on falls in a home-bound older
      population.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2010</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in 25-hydroxyvitamin D Levels Over 5 Months</measure>
    <time_frame>5 months</time_frame>
    <description>Determine the effectiveness of the intervention on improving 25-hydroxyvitamin D levels (change in 25(OH)D from baseline to 5-month follow-up). Measured as 5-month follow-up 25(OH)D level minus baseline 25(OH)D level.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Falls</measure>
    <time_frame>5 months</time_frame>
    <description>Determine the effectiveness of the intervention on reducing the number of falls using monthly fall calendars (compare the average number of falls in vitamin D3 group vs. active placebo group over 5 months)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Were Compliant to Intervention</measure>
    <time_frame>5 months</time_frame>
    <description>Number of participants who consumed at least 4 out of a possible 5 supplement doses (=&gt;80% compliance) over 5 months.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <condition>Accidental Falls</condition>
  <arm_group>
    <arm_group_label>Vitamin D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100,000 IU vitamin D3 once monthly</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin E</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>400 IU vitamin E once monthly</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>100,000 IU vitamin D3 once monthly for 5 months</description>
    <arm_group_label>Vitamin D3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin E</intervention_name>
    <description>400 IU vitamin E once monthly for 5 months</description>
    <arm_group_label>Vitamin E</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 65 years old

          -  Forsyth County Senior Services Meals-on-Wheels recipient

          -  Willing to provide informed consent

          -  Willing to be randomized to vitamin D or active placebo control

        Exclusion Criteria:

          -  Hyperparathyroidism

          -  Kidney stones (within the past 2 years)

          -  History of hypercalcemia

          -  On dialysis

          -  Inability or contraindications to consume vitamin D supplements

          -  Taking prescription vitamin D2 or vitamin D3-containing supplements totaling &gt; 1000
             IU/d

          -  Planning to move within the next 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Denise K Houston, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest University</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>August 3, 2011</study_first_submitted>
  <study_first_submitted_qc>August 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2011</study_first_posted>
  <results_first_submitted>June 5, 2019</results_first_submitted>
  <results_first_submitted_qc>July 31, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">September 9, 2019</results_first_posted>
  <last_update_submitted>July 31, 2019</last_update_submitted>
  <last_update_submitted_qc>July 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitamin D</keyword>
  <keyword>falls</keyword>
  <keyword>deficiency</keyword>
  <keyword>insufficiency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Vitamin D3</title>
          <description>100,000 IU vitamin D3 once monthly
Vitamin D3: 100,000 IU vitamin D3 once monthly for 5 months</description>
        </group>
        <group group_id="P2">
          <title>Vitamin E</title>
          <description>400 IU vitamin E once monthly
Vitamin E: 400 IU vitamin E once monthly for 5 months</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Vitamin D3</title>
          <description>100,000 IU vitamin D3 once monthly
Vitamin D3: 100,000 IU vitamin D3 once monthly for 5 months</description>
        </group>
        <group group_id="B2">
          <title>Vitamin E</title>
          <description>400 IU vitamin E once monthly
Vitamin E: 400 IU vitamin E once monthly for 5 months</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="38"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="68"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77.6" spread="9.0"/>
                    <measurement group_id="B2" value="78.2" spread="8.4"/>
                    <measurement group_id="B3" value="77.9" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in 25-hydroxyvitamin D Levels Over 5 Months</title>
        <description>Determine the effectiveness of the intervention on improving 25-hydroxyvitamin D levels (change in 25(OH)D from baseline to 5-month follow-up). Measured as 5-month follow-up 25(OH)D level minus baseline 25(OH)D level.</description>
        <time_frame>5 months</time_frame>
        <population>Participants who did not have a 5 month follow-up visit (n=4) and those who did not have baseline and/or follow-up blood samples (n=7) were excluded from the analysis leaving an analysis sample of 57 participants</population>
        <group_list>
          <group group_id="O1">
            <title>Vitamin D3</title>
            <description>100,000 IU vitamin D3 once monthly
Vitamin D3: 100,000 IU vitamin D3 once monthly for 5 months</description>
          </group>
          <group group_id="O2">
            <title>Vitamin E</title>
            <description>400 IU vitamin E once monthly
Vitamin E: 400 IU vitamin E once monthly for 5 months</description>
          </group>
        </group_list>
        <measure>
          <title>Change in 25-hydroxyvitamin D Levels Over 5 Months</title>
          <description>Determine the effectiveness of the intervention on improving 25-hydroxyvitamin D levels (change in 25(OH)D from baseline to 5-month follow-up). Measured as 5-month follow-up 25(OH)D level minus baseline 25(OH)D level.</description>
          <population>Participants who did not have a 5 month follow-up visit (n=4) and those who did not have baseline and/or follow-up blood samples (n=7) were excluded from the analysis leaving an analysis sample of 57 participants</population>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.7" spread="3.1"/>
                    <measurement group_id="O2" value="0" spread="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Falls</title>
        <description>Determine the effectiveness of the intervention on reducing the number of falls using monthly fall calendars (compare the average number of falls in vitamin D3 group vs. active placebo group over 5 months)</description>
        <time_frame>5 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin D3</title>
            <description>100,000 IU vitamin D3 once monthly
Vitamin D3: 100,000 IU vitamin D3 once monthly for 5 months</description>
          </group>
          <group group_id="O2">
            <title>Vitamin E</title>
            <description>400 IU vitamin E once monthly
Vitamin E: 400 IU vitamin E once monthly for 5 months</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Falls</title>
          <description>Determine the effectiveness of the intervention on reducing the number of falls using monthly fall calendars (compare the average number of falls in vitamin D3 group vs. active placebo group over 5 months)</description>
          <units>falls/participant</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="1.1" lower_limit="0" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Were Compliant to Intervention</title>
        <description>Number of participants who consumed at least 4 out of a possible 5 supplement doses (=&gt;80% compliance) over 5 months.</description>
        <time_frame>5 months</time_frame>
        <population>Compliance assessed in participants who remained in the study over the 5 month intervention for an analysis sample of 64 participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Vitamin D3</title>
            <description>100,000 IU vitamin D3 once monthly
Vitamin D3: 100,000 IU vitamin D3 once monthly for 5 months</description>
          </group>
          <group group_id="O2">
            <title>Vitamin E</title>
            <description>400 IU vitamin E once monthly
Vitamin E: 400 IU vitamin E once monthly for 5 months</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Were Compliant to Intervention</title>
          <description>Number of participants who consumed at least 4 out of a possible 5 supplement doses (=&gt;80% compliance) over 5 months.</description>
          <population>Compliance assessed in participants who remained in the study over the 5 month intervention for an analysis sample of 64 participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Vitamin D3</title>
          <description>100,000 IU vitamin D3 once monthly
Vitamin D3: 100,000 IU vitamin D3 once monthly for 5 months</description>
        </group>
        <group group_id="E2">
          <title>Vitamin E</title>
          <description>400 IU vitamin E once monthly
Vitamin E: 400 IU vitamin E once monthly for 5 months</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Denise Houston</name_or_title>
      <organization>Wake Forest School of Medicine</organization>
      <phone>336-713-8558</phone>
      <email>dhouston@wakehealth.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

